Basp Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.80 M
- Company Age 44 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.20 M
- Revenue Growth %
- Profit Growth 12.45%
- Ebitda 15.62%
- Net Worth -0.41%
- Total Assets -0.02%
About Basp Life Sciences
Basp Life Sciences Private Limited (BLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 1980 and has a history of 44 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.80 M.
The company currently has active open charges totaling ₹2.20 M.
Bapusaheb Patil, Vikrant Patil, and Peshwa Patil serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1980PTC022200
-
Company No.
022200
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 1980
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Basp Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikrant Patil
|
Director | 01-Feb-1998 | Current |
|
Peshwa Patil
|
Director | 12-Jan-1998 | Current |
|
Bapusaheb Patil
|
Director | 06-Feb-1980 | Current |
Financial Performance of Basp Life Sciences.
Basp Life Sciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.45% increase in profit. The company's net worth dipped by a decrease of 0.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Basp Life Sciences?
In 2021, Basp Life Sciences had a promoter holding of 90.67% and a public holding of 9.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Molecular Products Group India Private LimitedVikrant Patil is a mutual person
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 1997 | State Bank Of India | ₹0.40 M | Open |
| 27 Jun 1996 | State Bank Of India | ₹1.80 M | Open |
How Many Employees Work at Basp Life Sciences?
Unlock and access historical data on people associated with Basp Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Basp Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basp Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.